Synthesis Peptides Uses HPLC and Mass Spectrometry to Document Purity for 40-Plus Research Compounds
Las Vegas, United States - August 24, 2026 / Synthesis Peptides /
Synthesis Peptides, a U.S. veteran-owned supplier of research peptides, has completed a full-catalog expansion of its third-party laboratory testing program, extending independent verification to all 40-plus compounds currently listed for sale. Each batch now ships with a Certificate of Analysis documenting analytical peptide purity through two distinct methodologies: high-performance liquid chromatography (HPLC) and mass spectrometry.
The expansion formalizes a documentation standard that applies uniformly across the entire compound catalog. Certificates of Analysis are generated from data produced by external laboratories rather than internal assessments, providing scientific buyers with an independently sourced analytical record when sourcing compounds for in vitro laboratory work.
HPLC and Mass Spectrometry as Verification Standards
The dual-method testing approach applies two complementary analytical techniques to each peptide batch. HPLC separates compound components to identify and quantify impurities, while mass spectrometry confirms molecular identity by measuring the mass-to-charge ratio of ionized particles. Together, the two methods address both purity percentage and structural confirmation - two distinct dimensions of compound quality that bear directly on the reproducibility of downstream research outcomes.
All compounds supplied by Synthesis Peptides are intended strictly for in vitro research and laboratory use and are not approved for human or animal consumption, clinical application, or any use outside of controlled laboratory settings. The Certificates of Analysis accompany each order to allow researchers to assess compound specifications prior to experimental use.
Third-Party Laboratory Testing and Transparency for Researchers
Routing verification through independent third-party laboratory testing rather than relying solely on in-house analysis reflects a structural decision about how purity documentation is produced and presented. External laboratory involvement removes internal bias from the analytical process and gives research institutions, universities, and private laboratories an independently sourced data point when evaluating compound specifications.
Synthesis Peptides supplies more than 40 distinct peptide compounds, covering a range of sequences relevant to ongoing scientific inquiry in fields where in vitro experimentation is the standard research methodology. The Certificate of Analysis issued for each batch documents the specific purity percentage obtained through HPLC analysis alongside mass spectrometry confirmation of molecular weight, giving end users a complete analytical record for laboratory documentation purposes.
Veteran-Owned Infrastructure Serving the Scientific Research Community
Synthesis Peptides operates as a U.S. veteran-owned business, a designation that reflects the organizational structure and ownership of the company. The company's operational focus remains directed at the scientific research community, with catalog development, testing protocols, and documentation practices oriented toward institutional and professional research buyers rather than consumer markets.
The analytical peptide purity standards applied across the catalog are consistent regardless of compound type or order volume, meaning a single-unit purchase carries the same Certificate of Analysis documentation as a bulk order. This uniformity in testing protocol across all 40-plus compounds is intended to give researchers a predictable documentation baseline when incorporating externally sourced research peptides into laboratory workflows.
Researchers accessing the catalog can review available compound listings and corresponding analytical documentation through the company's platform, where Certificate of Analysis records are made accessible alongside product specifications. The testing and documentation process functions as the baseline standard applied to every compound in the catalog rather than as a premium or optional service tier.
About Synthesis Peptides
Synthesis Peptides is a U.S. veteran-owned supplier of research peptides serving the scientific research community. The company offers a catalog of more than 40 compounds, each verified for analytical peptide purity through independent third-party laboratory testing using HPLC and mass spectrometry. All products are intended strictly for in vitro laboratory research use only and are not for human or animal consumption.
Learn more at Synthesis Peptides
Contact Information:
Synthesis Peptides
3009 Hawksdale Dr, Unit #153
Las Vegas, NV 89134
United States
Christian Miller
+1 (702) 381-4170
https://synthesispeptides.co